It’s finally here!
A whopping 19 months after being sent in for regulatory review, JnJ’s new integrated Animas Vibe insulin pump + continuous glucose monitor has gotten the green light from the FDA to be sold in the United States! (See also: it finally got some ‘good vibes’ from regulators )
Word came early Monday morning in the form a press announcement that on Nov. 25, the FDA had finally OK’d the Animas Vibe —…
It’s finally here!
Years ago, I used to think of the FDA as a big, monolithic mystery agency that regulated my diabetes devices from some dark back room in the nation’s capitol, weighing in on the importance and safety of said devices like the Gods from Olympus.
More often than not, they seemed to throw lightening bolts of denial and delay. And no, you didn’t get to question or interfere in that decision-making, lest you be cast out…
Our correspondent Wil Dubois is on the scene at the big annual American Association of Diabetes Educators (AADE) meeting in Orlando, FL, this week covering the action live.
We’ll be bringing you several full reports from Wil on both conference sessions and product updates, starting with this one on some of the most exciting breaking news on the diabetes device & data front that just can’t wait… because, hey, #WeAreNotWaiting!
Snap Pump to Smartphone…
Medtronic is leading the charge on new diabetes devices again, with a first-of-its-kind combo device launched in Europe that brings a continuous glucose monitoring (CGM) sensor and insulin infusion set together into a single device with combined insertion capability!
The company announced its launch of the Minimed Duo on Tuesday, after getting CE Mark approval for European sale early this week.
The new Duo uses the Minimed Veo system (which is the 2009-approved European version…
This month the Diabetes Social Media Advocacy (DSMA) blog carnival is taking a personal look how technology and its outputs affect our D-lives.
It refers to the #WeAreNotWaiting campaign, a D-Community push for diabetes innovation now.
It’s a grassroots initiative calling for diabetes data and device interoperability — so that we PWDs have full access to our own data, can share it as we like, and can use on whatever apps or platforms we choose…Read more »